Literature DB >> 23757620

The syndrome of hypoparathyroidism, deafness, and renal anomalies.

Jagriti Upadhyay1, Devin W Steenkamp, Jeff M Milunsky.   

Abstract

OBJECTIVE: We review the syndrome of hypoparathyroidism, deafness, and renal anomalies (HDR syndrome).
METHODS: The current understanding and relevant literature pertaining to the background, genetic considerations, clinical features, prognosis, and treatment of HDR syndrome are reviewed.
RESULTS: The combination of hypoparathyroidism, deafness, and renal anomalies constitutes an unusual syndrome associated most commonly with haploinsufficiency in GATA3, which encodes a transcription factor that binds to the (A/T) GATA (A/G) consensus DNA sequence. Sensorineural hearing loss is the most consistently expressed clinical feature, being present in almost all affected individuals, and the combination of hypoparathyroidism and hearing impairment occurs in well over 90% of those affected, with various renal anomalies being the most heterogeneous feature of the classic triad. We characterize, in tabular form, the individual cases described in the literature and propose a classification scheme based on the presence or absence of renal anomalies. We also include the specific genetic abnormality and renal anomaly associated with each individual case.
CONCLUSION: HDR syndrome is a heterogeneous syndrome most commonly associated with GATA3 haploinsufficiency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23757620     DOI: 10.4158/EP13050.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  7 in total

1.  Vitamin D deficiency in a patient with HDR syndrome.

Authors:  Ifigenia Kostoglou-Athanassiou; Dimitrios Stefanopoulos; Areti Karfi; Panagiotis Athanassiou
Journal:  BMJ Case Rep       Date:  2015-07-08

Review 2.  Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Anthony J Bleyer; Kendrah Kidd; Martina Živná; Stanislav Kmoch
Journal:  Adv Chronic Kidney Dis       Date:  2017-03       Impact factor: 3.620

3.  A Case of HDR Syndrome and Ichthyosis: Dual Diagnosis by Whole-Genome Sequencing of Novel Mutations in GATA3 and STS Genes.

Authors:  Gregory Goodwin; Pamela P Hawley; David T Miller
Journal:  J Clin Endocrinol Metab       Date:  2016-01-05       Impact factor: 5.958

4.  The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.

Authors:  Chong Kun Cheon; Gu Hwan Kim; Han Wook Yoo
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

5.  A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.

Authors:  Tetsuji Okawa; Masanori Yoshida; Takeshi Usui; Takahiro Kudou; Yasumasa Iwasaki; Kazuki Fukuoka; Norio Takahashi; Yuka Uehara; Yutaka Oiso
Journal:  BMC Endocr Disord       Date:  2015-10-30       Impact factor: 2.763

6.  Clinical Auditory Phenotypes Associated with GATA3 Gene Mutations in Familial Hypoparathyroidism-deafness-renal Dysplasia Syndrome.

Authors:  Li Wang; Qiong-Fen Lin; Hong-Yang Wang; Jing Guan; Lan Lan; Lin-Yi Xie; Lan Yu; Ju Yang; Cui Zhao; Jin-Long Liang; Han-Lin Zhou; Huan-Ming Yang; Wen-Ping Xiong; Qiu-Jing Zhang; Da-Yong Wang; Qiu-Ju Wang
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

7.  Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.

Authors:  Marianne C Astor; Kristian Løvås; Aleksandra Debowska; Erik F Eriksen; Johan A Evang; Christian Fossum; Kristian J Fougner; Synnøve E Holte; Kari Lima; Ragnar B Moe; Anne Grethe Myhre; E Helen Kemp; Bjørn G Nedrebø; Johan Svartberg; Eystein S Husebye
Journal:  J Clin Endocrinol Metab       Date:  2016-05-17       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.